Mirada recruits German hospital

Article

University Hospital Essen has signed an agreement with Mirada Solutions, a unit of CTI Molecular Imaging, to serve as the company's first European clinical reference site. German physicians will use Mirada software in a combined PET/CT environment to

University Hospital Essen has signed an agreement with Mirada Solutions, a unit of CTI Molecular Imaging, to serve as the company's first European clinical reference site. German physicians will use Mirada software in a combined PET/CT environment to address software fusion requirements as a complement to conventional hardware-based techniques. The hospital has been working with PET/CT imaging since October 2001. The collaboration is the first step toward establishing R&D partnerships among leading European institutions, CTI, and its subsidiaries, including Mirada Solutions and PETNET Pharmaceuticals. Mirada joined CTI Aug. 18, when CTI purchased all of Mirada's capital stock.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.